The Allstate Corporation (ALL) 10-Year Financial Performance & Capital Metrics

ALL • • Insurance & Managed Care

Financial ServicesProperty & Casualty InsurancePersonal Lines InsuranceMainstream Personal Auto & Home

AboutThe Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. The company operates through Allstate Protection; Protection Services; Allstate Health and Benefits; and Run-off Property-Liability segments. The Allstate Protection segment offers private passenger auto and homeowners insurance; specialty auto products, including motorcycle, trailer, motor home, and off-road vehicle insurance; other personal lines products, such as renter, condominium, landlord, boat, umbrella, and manufactured home and stand-alone scheduled personal property; and commercial lines products under the Allstate and Encompass brand names. The Protection Services segment provides consumer product protection plans and related technical support for mobile phones, consumer electronics, furniture, and appliances; finance and insurance products, including vehicle service contracts, guaranteed asset protection waivers, road hazard tire and wheel, and paint and fabric protection; roadside assistance; device and mobile data collection services; data and analytic solutions using automotive telematics information; and identity protection services. This segment offers its products under various brands including Allstate Protection Plans, Allstate Dealer Services, Allstate Roadside Services, Arity, and Allstate Identity Protection. The Allstate Health and Benefits provides life, accident, critical illness, short-term disability, and other health insurance products. The Run-off Property-Liability offers property and casualty insurance. It sells its products through call centers, agencies, financial specialists, independent agents, brokers, wholesale partners, and affinity groups, as well as through online and mobile applications. The Allstate Corporation was founded in 1931 and is based in Northbrook, Illinois.Show more

Revenue $63.52B +12.2%
Combined Ratio 90.93% -9.6%
Net Income $4.67B +2582.4%
Return on Equity 23.94% +2327.6%
Medical Cost Ratio 77.17% -11.6%
Operating Margin 9.07% +1575.0%
Net Margin 7.35% +2311.8%
ROA 4.34% +2425.5%
Equity / Assets 19.14% +12.2%
Book Value per Share 79.79 +18.8%
Tangible BV/Share 64.85 +29.3%
Debt/Equity 0.38 -16.0%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Profitable underwriting: 90.9% combined ratio
✓Strong Piotroski F-Score: 7/9
✓11 consecutive years of dividend growth

✗Weaknesses

No significant weaknesses identified

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y6.07%

5Y9.09%

3Y9.27%

TTM6.88%

Profit (Net Income) CAGR

10Y5.06%

5Y-0.75%

3Y42.47%

TTM98.16%

EPS CAGR

10Y10.48%

5Y3.9%

3Y-0.5%

TTM99.44%

ROCE

10Y Avg3.35%

5Y Avg2.89%

3Y Avg1.05%

Latest5.36%

Peer Comparison

Mainstream Personal Auto & Home

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
PGRThe Progressive Corporation	119.3B	203.52	14.13	21.36%	12.66%	32%	12.43%	0.27
ALLThe Allstate Corporation	51.15B	195.47	11.51	12.24%	12.65%	30.48%	17.05%	0.38

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Revenue+	35.65B	37.4B	39.41B	39.81B	41.1B	41.69B	48.68B	50.62B	56.59B	63.52B
Revenue Growth %	0.01%	0.05%	0.05%	0.01%	0.03%	0.01%	0.17%	0.04%	0.12%	0.12%
Medical Costs & Claims+	27.96B	29.35B	29.24B	30.63B	29.96B	28.66B	36.65B	44.94B	49.42B	49.02B
Medical Cost Ratio %	-	-	-	-	-	-	-	-	-	-
Gross Profit+	7.69B	8.04B	10.16B	9.19B	11.14B	13.03B	12.03B	5.68B	7.17B	14.5B
Gross Margin %	-	-	-	-	-	-	-	-	-	-
Gross Profit Growth %	-0.14%	0.05%	0.26%	-0.1%	0.21%	0.17%	-0.08%	-0.53%	0.26%	1.02%
Operating Expenses+	4.41B	5.29B	5.61B	6.56B	5.7B	6.22B	5.57B	7.51B	7.52B	8.74B
OpEx / Revenue %	-	-	-	-	-	-	-	-	-	-
Depreciation & Amortization	371M	382M	483M	511M	647M	686M	1.09B	847M	704M	555M
Combined Ratio %	-	-	-	-	-	-	-	-	-	-
Operating Income+	3.28B	2.75B	4.55B	2.63B	5.44B	6.8B	6.47B	-1.83B	-348M	5.76B
Operating Margin %	-	-	-	-	-	-	-	-	-	-
Operating Income Growth %	-0.23%	-0.16%	0.65%	-0.42%	1.07%	0.25%	-0.05%	-1.28%	0.81%	17.55%
EBITDA+	3.65B	3.14B	5.03B	3.14B	6.09B	7.49B	7.55B	-983M	356M	6.32B
EBITDA Margin %	-	-	-	-	-	-	-	-	-	-
Interest Expense	292M	295M	335M	332M	327M	318M	330M	335M	379M	400M
Non-Operating Income	-292M	-295M	-335M	-332M	-327M	-318M	-330M	-335M	-379M	-400M
Pretax Income+	3.28B	2.75B	4.55B	2.63B	5.44B	6.8B	6.47B	-1.83B	-348M	5.76B
Pretax Margin %	-	-	-	-	-	-	-	-	-	-
Income Tax+	1.11B	877M	995M	468M	1.12B	1.37B	1.29B	-488M	-135M	1.16B
Effective Tax Rate %	-	-	-	-	-	-	-	-	-	-
Net Income+	2.17B	1.88B	3.55B	2.16B	4.85B	5.58B	1.61B	-1.29B	-188M	4.67B
Net Margin %	-	-	-	-	-	-	-	-	-	-
Net Income Growth %	-0.24%	-0.14%	0.89%	-0.39%	1.24%	0.15%	-0.71%	-1.8%	0.85%	25.82%
EPS (Diluted)+	5.05	4.67	9.35	6.12	14.03	17.31	17.25	-5.03	-1.20	16.99
EPS Growth %	-0.19%	-0.08%	1%	-0.35%	1.29%	0.23%	-0%	-1.29%	0.76%	15.16%
EPS (Basic)	5.12	4.72	9.50	6.21	14.25	17.53	17.50	-5.03	-1.20	17.22
Diluted Shares Outstanding	406.8M	377.3M	367.8M	353.2M	333.5M	315.5M	299.1M	271.2M	262.5M	267.8M

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Assets+	104.66B	108.61B	112.42B	112.25B	119.95B	125.99B	99.44B	97.99B	103.36B	111.62B
Asset Growth %	-0.04%	0.04%	0.04%	-0%	0.07%	0.05%	-0.21%	-0.01%	0.05%	0.08%
Total Investment Assets+	4.87B	5.81B	6.74B	7.5B	8.08B	4.56B	8.02B	8.11B	8.38B	9.26B
Long-Term Investments	2.75B	1.53B	4.8B	4.48B	3.82B	-2.24B	4.01B	3.94B	3.24B	4.72B
Short-Term Investments	2.12B	4.29B	1.94B	3.03B	4.26B	6.81B	4.01B	4.17B	5.14B	4.54B
Total Current Assets+	16.68B	19.07B	17.27B	19.25B	20.28B	20.8B	23.16B	23.69B	24.72B	24.78B
Cash & Equivalents	495M	436M	617M	499M	338M	311M	763M	736M	722M	704M
Receivables	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Other Current Assets	0	0	0	0	0	0	0	0	0	0
Goodwill & Intangibles+	1.22B	1.22B	2.74B	3.24B	3.03B	2.82B	4.92B	4.68B	4.47B	4B
Goodwill	1.22B	1.22B	2.18B	2.53B	2.54B	2.37B	3.5B	3.5B	3.5B	3.25B
Intangible Assets	0	0	556M	713M	481M	453M	1.42B	1.18B	966M	754M
PP&E (Net)	1.02B	1.06B	1.07B	1.04B	1.15B	1.06B	939M	987M	859M	669M
Other Assets	82.98B	85.73B	86.55B	84.24B	91.68B	103.56B	66.41B	64.31B	69.86B	77.22B
Total Liabilities	84.63B	88.04B	89.87B	90.94B	93.95B	95.77B	74.31B	80.63B	85.73B	90.25B
Total Debt+	5.12B	6.35B	6.35B	6.45B	6.63B	7.83B	7.98B	7.96B	7.94B	8.09B
Net Debt	4.63B	5.91B	5.73B	5.95B	6.29B	7.51B	7.21B	7.23B	7.22B	7.38B
Long-Term Debt	5.12B	6.35B	6.35B	6.45B	6.63B	7.83B	7.98B	7.96B	7.94B	8.09B
Short-Term Debt	0	0	0	0	0	0	0	0	0	0
Total Current Liabilities+	11.2B	12.78B	13.11B	14.89B	16.06B	0	0	0	0	0
Accounts Payable	5.89B	6.18B	6.47B	7.16B	6.91B	0	0	0	0	0
Deferred Revenue	0	0	0	0	0	0	0	0	0	0
Other Current Liabilities	0	0	0	0	0	0	0	0	0	0
Deferred Taxes	1000K	1000K	1000K	1000K	1000K	1000K	1000K	0	0	0
Other Liabilities	68.22B	68.42B	69.63B	69.17B	70.11B	87.56B	65.5B	72.66B	77.79B	82.17B
Total Equity+	20.02B	20.57B	22.55B	21.31B	26B	30.22B	25.13B	17.36B	17.63B	21.37B
Equity Growth %	-0.1%	0.03%	0.1%	-0.05%	0.22%	0.16%	-0.17%	-0.31%	0.02%	0.21%
Shareholders Equity	20.02B	20.57B	22.55B	21.31B	26B	30.22B	25.18B	17.49B	17.77B	21.44B
Minority Interest	0	0	0	0	0	0	-52M	-125M	-140M	-75M
Retained Earnings	39.41B	40.68B	43.16B	44.03B	48.07B	52.77B	53.29B	50.97B	49.72B	53.29B
Common Stock	9M	9M	9M	9M	9M	9M	9M	9M	9M	9M
Accumulated OCI	-768M	-422M	303M	115M	1.95B	3.3B	655M	-2.39B	-700M	-889M
Return on Equity (ROE)	0.1%	0.09%	0.16%	0.1%	0.2%	0.2%	0.06%	-0.06%	-0.01%	0.24%
Return on Assets (ROA)	0.02%	0.02%	0.03%	0.02%	0.04%	0.05%	0.01%	-0.01%	-0%	0.04%
Equity / Assets	-	-	-	-	-	-	-	-	-	-
Debt / Equity	0.26x	0.31x	0.28x	0.30x	0.26x	0.26x	0.32x	0.46x	0.45x	0.38x
Book Value per Share	49.23	54.53	61.31	60.34	77.96	95.77	84.01	64.02	67.16	79.79
Tangible BV per Share	-	-	-	-	-	-	-	-	-	-

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	3.62B	3.99B	4.31B	5.17B	5.13B	5.49B	5.12B	5.12B	4.23B	8.93B
Operating CF Growth %	0.12%	0.1%	0.08%	0.2%	-0.01%	0.07%	-0.07%	0%	-0.17%	1.11%
Operating CF / Revenue %	-	-	-	-	-	-	-	-	-	-
Net Income	2.17B	1.88B	3.19B	2.16B	4.85B	5.58B	1.57B	-1.36B	-213M	4.6B
Depreciation & Amortization	371M	382M	483M	511M	647M	686M	1.09B	847M	704M	555M
Stock-Based Compensation	26M	35M	0	138M	120M	137M	129M	102M	0	0
Deferred Taxes	0	0	0	0	-120M	-137M	-129M	-102M	0	0
Other Non-Cash Items	728M	811M	350M	1.85B	-1.03B	-773M	2.55B	5.69B	309M	188M
Working Capital Changes	346M	923M	292M	511M	666M	2M	-88M	-53M	3.43B	3.59B
Cash from Investing+	742M	-2.53B	-1.21B	-1.72B	-2.81B	-3.44B	510M	-1.73B	-3B	-8.25B
Capital Expenditures	-303M	-313M	-299M	-277M	-433M	-308M	-345M	-420M	-267M	-210M
Acquisitions	-242M	-569M	-1.67B	-1.47B	-594M	86M	-2.42B	-288M	-180M	5M
Purchase of Investments	-36.67B	-37.32B	-38.76B	-44.36B	-39.88B	-47.01B	-41.91B	-46.51B	-33.27B	0
Sale/Maturity of Investments	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	0
Other Investing	-143M	-145M	-46M	-135M	-149M	653M	639M	268M	-37M	-8.05B
Cash from Financing+	-4.52B	-1.53B	-2.92B	-3.57B	-2.48B	-2.01B	-5.24B	-3.42B	-1.24B	-697M
Dividends Paid	-599M	-602M	-641M	-748M	-787M	-776M	-999M	-1.03B	-1.03B	-1.08B
Share Repurchases	-2.81B	-1.34B	-1.5B	-2.69B	-2.87B	-2.02B	-3.57B	-2.52B	-335M	-2M
Stock Issued	0	0	0	557M	1.53B	63M	114M	0	0	0
Debt Issuance (Net)	-1000K	1000K	0	1000K	1000K	1000K	-1000K	0	-1000K	1000K
Other Financing	-1.09B	-806M	-787M	-793M	-537M	-462M	-349M	131M	119M	239M
Net Change in Cash+	-162M	-59M	181M	-118M	-161M	39M	452M	-27M	-14M	-18M
Exchange Rate Effect	0	0	0	0	0	0	1000K	0	0	0
Cash at Beginning	657M	495M	436M	617M	499M	338M	311M	763M	736M	722M
Cash at End	495M	436M	617M	499M	338M	377M	763M	736M	722M	704M
Free Cash Flow+	3.31B	3.68B	4.01B	4.9B	4.7B	5.18B	4.77B	4.7B	3.96B	8.72B
FCF Growth %	0.12%	0.11%	0.09%	0.22%	-0.04%	0.1%	-0.08%	-0.01%	-0.16%	1.2%
FCF Margin %	-	-	-	-	-	-	-	-	-	-
FCF per Share	8.14	9.75	10.92	13.87	14.08	16.43	15.95	17.33	15.09	32.57

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Combined Ratio	90.79%	92.64%	88.46%	93.4%	86.76%	83.69%	86.72%	103.62%	100.61%	90.93%
Medical Cost Ratio	78.43%	78.49%	74.21%	76.92%	72.9%	68.75%	75.28%	88.78%	87.33%	77.17%
Return on Equity (ROE)	10.26%	9.25%	16.48%	9.85%	20.49%	19.84%	5.83%	-6.07%	-1.07%	23.94%
Return on Assets (ROA)	2.04%	1.76%	3.22%	1.92%	4.17%	4.53%	1.43%	-1.31%	-0.19%	4.34%
Equity / Assets	19.13%	18.94%	20.06%	18.99%	21.67%	23.98%	25.27%	17.72%	17.06%	19.14%
Book Value / Share	49.23	54.53	61.31	60.34	77.96	95.77	84.01	64.02	67.16	79.79
Debt / Equity	0.26x	0.31x	0.28x	0.30x	0.26x	0.26x	0.32x	0.46x	0.45x	0.38x
Revenue Growth	1.17%	4.9%	5.37%	1.04%	3.24%	1.43%	16.76%	3.98%	11.8%	12.24%

Revenue by Segment

	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Property Liability	30.31B	32.57B	33.31B	34.51B	38.59B	38.73B	46.03B	46.64B	51.9B	58.34B
Property Liability Growth	-	7.45%	2.29%	3.61%	11.80%	0.36%	18.86%	1.32%	11.28%	12.42%
Protection Services	-	-	993M	1.32B	1.65B	1.92B	2.36B	2.49B	2.77B	3.22B
Protection Services Growth	-	-	-	32.73%	25.11%	16.56%	22.84%	5.34%	11.50%	16.23%
Allstate Health And Benefits	-	-	1.16B	1.2B	1.24B	1.18B	2.26B	2.26B	2.38B	2.54B
Allstate Health And Benefits Growth	-	-	-	3.98%	3.08%	-4.84%	91.61%	-0.04%	5.22%	6.73%
Corporate and Other	-	39M	35M	33M	94M	106M	111M	176M	183M	-
Corporate and Other Growth	-	-	-10.26%	-5.71%	184.85%	12.77%	4.72%	58.56%	3.98%	-
Intersegment Eliminations	-	-	-110M	-122M	-154M	-147M	-175M	-149M	-138M	-
Intersegment Eliminations Growth	-	-	-	-10.91%	-26.23%	4.55%	-19.05%	14.86%	7.38%	-
Allstate Life	-	-	1.77B	1.93B	1.98B	1.95B	-	-	-	-
Allstate Life Growth	-	-	-	8.51%	3.01%	-1.51%	-	-	-	-
Allstate Annuities	-	-	1.36B	945M	1.28B	1.05B	-	-	-	-
Allstate Annuities Growth	-	-	-	-30.67%	35.03%	-17.71%	-	-	-	-
Allstate Financial	2.16B	3.93B	-	-	-	-	-	-	-	-
Allstate Financial Growth	-	82.02%	-	-	-	-	-	-	-	-
Discontinued Lines and Coverages	-	-	-	-	-	-	-	-	-	-
Discontinued Lines and Coverages Growth	-	-	-	-	-	-	-	-	-	-

Revenue by Geography

	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
United States	-	35.47B	37.38B	38.55B	43.21B	43.03B	48.5B	49.21B	54.69B	-
United States Growth	-	-	5.37%	3.14%	12.08%	-0.41%	12.69%	1.48%	11.12%	-
Non-United States	-	1.06B	1.11B	1.2B	1.37B	1.57B	1.86B	1.94B	2.06B	-
Non-United States Growth	-	-	4.72%	8.11%	14.17%	14.60%	18.47%	4.30%	6.19%	-
European Union	-	-	35M	61M	95M	188M	232M	258M	346M	-
European Union Growth	-	-	-	74.29%	55.74%	97.89%	23.40%	11.21%	34.11%	-

Frequently Asked Questions

Valuation & Price

The Allstate Corporation (ALL) has a price-to-earnings (P/E) ratio of 11.5x. This may indicate the stock is undervalued or faces growth challenges.

Growth & Financials

The Allstate Corporation (ALL) grew revenue by 12.2% over the past year. This is steady growth.

Yes, The Allstate Corporation (ALL) is profitable, generating $8.38B in net income for fiscal year 2024 (7.3% net margin).

Dividend & Returns

Yes, The Allstate Corporation (ALL) pays a dividend with a yield of 1.84%. This makes it attractive for income-focused investors.

The Allstate Corporation (ALL) has a return on equity (ROE) of 23.9%. This is excellent, indicating efficient use of shareholder capital.

Industry Metrics

The Allstate Corporation (ALL) has a combined ratio of 90.9%. A ratio below 100% indicates underwriting profitability.

US Stock Screener

...